We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 25, 2017

Doxorubicin and Trastuzumab Associated With LVEF Decline



Additional Info

Disclosure statements are available on the authors' profiles:

Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Followup
Circulation 2017 Jan 19;[EPub Ahead of Print], HK Narayan, BS Finkelman, B French, T Plappert, D Hyman, AM Smith, KB Margulies, B Ky

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.